Results 171 to 180 of about 109,035 (264)

Pregnancy after heart and kidney transplantation: a case report

JHLT Open
Background: The risk of pregnancy-associated complications is considerably elevated in transplant recipients compared to the general population, and it should be managed aggressively to preserve the allograft function and avoid complications.
Farnaz Ahmadi, Farah Naghashzadeh, Zargham Hossein Ahmadi, Babak Sharif-Kashani, Seyed Mohammad Reza Nejatollahi, Shakiba Khodadad, Seyed Mohsen Mirhossein, Zahra Ansari Aval, Alireza Jahangirifard, Leila Saliminejad, Sourena Sharif-Kashani, Shadi Shafaghi, Sima Noorali   +12 more
doaj  

Aerobic exercise training for chronic obstructive pulmonary disease: What is the best regimen to increase heart rate variability? [PDF]

J Res Med Sci
Abedi M, Mirtajani SB, Firouzabadi SR, Zahiri R, Mirenayat MS.   +4 more
europepmc   +1 more source

Oxidative Stress in Antigen Processing and Presentation

MedComm – Oncology, Volume 4, Issue 2, June 2025.
Reactive oxygen species (ROS) play a crucial role in antigen processing and presentation, essential for linking innate and adaptive immunity. While balanced ROS levels promote immune function, excess ROS can disrupt antigen recognition, resulting in immune dysfunction.
Qinxia Chang, Yaying Zhang, Xiaojun Liu, Peng Miao, Wenbing Pu, Shanshan Liu, Jing Zhang, Yuan Tian, Guobo Shen, Na Xie   +9 more
wiley   +1 more source

Complete resolution of non-tuberculous mycobacterial pulmonary nodule following cryobiopsy: The first case report. [PDF]

Diagn Pathol
Han SJ, Chung C, Park D.
europepmc   +1 more source

Association Between Ceftriaxone Use and Biliary Infections in Patients With Pneumonia: A Nationwide Retrospective Cohort Study

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 6, June 2025.
ABSTRACT Background Ceftriaxone is believed to increase the risk of biliary infections due to pseudolithiasis caused by ceftriaxone‐calcium precipitation, but this risk is not well understood. This study aimed to investigate whether ceftriaxone use is associated with an increased risk of biliary infections in pneumonia patients using a national ...
Jumpei Taniguchi, Shotaro Aso, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga   +4 more
wiley   +1 more source

Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry. [PDF]

BMC Rheumatol
El Ouardi N, Hmamouchi I, Abouqal R, Allali F, Bahiri R, El Bouchti I, Ghozlani I, Hassikou H, Ichchou L, Janani S, Harzy T, Niamane R, Bezza A, El Maghraoui A.   +13 more
europepmc   +1 more source

Pharmacogenetic Study of Anti‐TB Drugs in the Native Ancestry Peruvian Population

Pharmacology Research &Perspectives, Volume 13, Issue 3, June 2025.
ABSTRACT In Peru, 33 113 individuals were diagnosed with tuberculosis (TB) in 2023. While TB treatments are generally effective, 3.4% to 13% of cases are associated with significant adverse drug reactions, with drug‐induced liver injury (DILI) being the most prevalent.
Luis Jaramillo‐Valverde, Mary K. Horton, Julio A. Poterico, Cristina M. Lanata, Heinner Guio   +4 more
wiley   +1 more source

Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies. [PDF]

Expert Opin Pharmacother
Magodoro IM, Kotze LA, Stek CJ, West A, Le Roux A, Sobratee N, Taliep A, Hamada Y, Dave JA, Rangaka MX, Parihar SP, Wilkinson RJ.   +11 more
europepmc   +1 more source

Real‐world safety and effectiveness of guselkumab in patients with psoriasis: A post‐marketing surveillance study through up to week 52 in Japan

The Journal of Dermatology, Volume 52, Issue 6, Page 967-982, June 2025.
Abstract Guselkumab is a monoclonal antibody that binds to the p19 subunit of interleukin‐23 and inhibits its downstream signaling. The safety profile of guselkumab and its superior efficacy over placebo and adalimumab for the treatment of patients with moderate‐to‐severe psoriasis were reported in phase 3 studies conducted within and outside Japan. To
Yayoi Tada, Yukako Sugiura, Manami Kamishima, Shoya Takahashi, Yoshihito Tanaka, Junya Masuda, Keiichi Yamanaka   +6 more
wiley   +1 more source

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source